| |
|
|
Pittcon 2009, Chicago, IL, USA
08 March 2009 - 13 March 2009
The premier conference and exposition on laboratory sciences celebrates 60 years of service to the scientific community. Pittcon is the most comprehensive annual meeting on laboratory science in the world, offering a first class lab product exposition, a diverse, high quality technical program, unparallelled educational programs, and invaluable peer to peer networking opportunities.
|
DxRx Summit: Nucleic Acid Diagnostics & Therapeutics Summit, Boston, MA, USA
12 May 2009 - 13 May 2009
The Summit will be attended by investors, corporate management, business leaders, legal and regulatory advisors, clinical trial CROs and others who are interested in the diagnostic and therapeutic applications of DNA, RNAi, microRNA’s and antisense technology.
|
|
|
|
|
|
Senior Research Associate
Momenta Pharmaceuticals
Cambridge, MA, USA
|
|
|
Product Manager
Millipore Corporation
Billerica, MA, USA
|
|
|
Director of Marketing
KLAnderson & Assoc.
Torrance, CA, USA
|
|
|
Laboratory Technician
KLAnderson & Assoc.
Torrance, CA, USA
|
|
|
Project Manager
Evolution Life Science
South East, UK
|
|
|
Sales Specialist
Evolution Life Science
Cambridge/East Midlands, UK
|
|
|
Bioanalytical Scientist
Evolution Life Science
North West, UK
|
|
|
|
Characterization of nanosecond micro-mixers
1Section Enzymology – Department of Biotechnology – Delft University of Technology, Julianalaan 67, 2628 BC Delft, The Netherlands; 2MESA+ Research Institute - University of Twente, 7500 AE Enschede,
We have constructed two four-jet-tangential micro-mixers, one from stainless-steel to study reactions in a freeze-quench setup, instrumental-dead-time 60µs and one from glass allowing optical studies. Both mixers contain 70µm channels ending in premixing-chamber. After the premixing-chamber, the fluids enter a mixing-chamber and leaves at an orifice travelling further as a free jet, mixing-time 200 ns, jet flow 200 m/s, pressure 400 bar.
|
|
|
|
|
|
|
Multiplexed Diagnostics 2008 Market Report
Published May 2008
Multiplexed diagnostics are the wild west of medicine. Technology is established, regulation is limited and the number of new biomarkers exploding. First-movers are grabbing biomarker territories, combining independent measurements for efficiency and mining molecules for multivariate panels. All the while demand is high for improving diagnoses and predicting responses to treatment. The challenges, however, are uncertain reimbursement, unclear business models and ever-intensifying competition. On
|
Cancer Personalized Medicine 2008
Published July 2008
The Cancer Personalized Medicine marketplace represents the paradigm for personalized medicine market evolution and Select Biosciences focuses in this report on the various commercialized cancer predictor tests, their current status, traction in the marketplace, quantitative market opportunities, and the factors that are driving as well as challenging the expansion of this space. Personalized Medicine, especially as it relates to Cancer, is undergoing significant growth and this report focuses i
|
|
|